Kanaph Therapeutics카나프테라퓨틱스
0082N0 · KOSDAQ · ₩0082N0 · 카나프테라퓨틱스
₩10,030▲ ₩220 (2.24%)End-of-day · Oct 28, 2026 · End-of-day prices.
Margins
| TTM | 2025 | |
|---|---|---|
| Gross margin | — | — |
| Operating margin | −76.8% | −76.8% |
| Net margin | −639.5% | −639.5% |
Growth (year on year)
| TTM | 2025 | |
|---|---|---|
| Revenue growth | 0.0% | — |
| Operating income growth | 0.0% | — |
| Net income growth | 0.0% | — |
Returns
| TTM | 2025 | |
|---|---|---|
| Return on equity | −121.2% | −287.3% |
| Return on assets | −111.5% | −230.0% |
Leverage and liquidity
| TTM | 2025 | |
|---|---|---|
| Liabilities to equity | 4.4% | 24.9% |
| Net debt to equity | — | — |
| Current ratio | 3,630.7% | 587.3% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: Kanaph Therapeutics / 카나프테라퓨틱스 / 0082N0 / KRX:0082N0
Source: KRX statistical information